Acorda Therapeutics Inc (ACOR) Insider Trading
- $15,079,138.83
- $110,177,601.95
- March 16, 2023
- Scopia Capital Management Lp
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| March 16, 2023 | CEO | 10,156 | $0.60 | Buy | $6,093.60 | |
| March 17, 2022 | CEO | 2,289 | $1.70 | Sell | $3,891.30 | |
| Dec. 2, 2019 | CEO | 4,699 | $1.60 | Sell | $7,518.40 | |
| Dec. 2, 2019 | Insider | 2,227 | $1.60 | Sell | $3,563.20 | |
| Feb. 22, 2019 | Insider | 761 | $13.18 | Sell | $10,029.98 | |
| Jan. 30, 2019 | Major Shareholder | 7,000 | $16.01 | Sell | $112,070.00 | |
| Jan. 25, 2019 | Major Shareholder | 11,001 | $16.02 | Sell | $176,236.02 | |
| Jan. 23, 2019 | Major Shareholder | 97,843 | $16.01 | Sell | $1,566,466.43 | |
| Jan. 17, 2019 | Major Shareholder | 100,000 | $16.86 | Sell | $1,686,000.00 | |
| Jan. 15, 2019 | Major Shareholder | 1,700 | $16.60 | Sell | $28,220.00 | |
| Jan. 10, 2019 | Major Shareholder | 162,491 | $17.18 | Sell | $2,791,595.38 | |
| Jan. 7, 2019 | Major Shareholder | 75,000 | $16.56 | Sell | $1,242,000.00 | |
| Jan. 3, 2019 | Major Shareholder | 23,616 | $15.74 | Sell | $371,715.84 | |
| Dec. 28, 2018 | Major Shareholder | 52,891 | $14.99 | Sell | $792,836.09 | |
| Dec. 28, 2018 | Major Shareholder | 52,891 | $14.99 | Sell | $792,836.09 | |
| Dec. 26, 2018 | Major Shareholder | 50,000 | $14.66 | Sell | $733,000.00 | |
| Dec. 20, 2018 | Major Shareholder | 45,000 | $14.25 | Sell | $641,250.00 | |
| Dec. 18, 2018 | Major Shareholder | 121,853 | $16.78 | Sell | $2,044,693.34 | |
| Dec. 14, 2018 | Major Shareholder | 61,857 | $16.21 | Sell | $1,002,701.97 | |
| Dec. 12, 2018 | Major Shareholder | 300,000 | $16.30 | Sell | $4,890,000.00 | |
| Dec. 10, 2018 | Major Shareholder | 35,000 | $19.07 | Sell | $667,450.00 | |
| Dec. 6, 2018 | Major Shareholder | 43,801 | $18.58 | Sell | $813,822.58 | |
| Dec. 3, 2018 | Major Shareholder | 225,000 | $20.51 | Sell | $4,614,750.00 | |
| Dec. 3, 2018 | Insider | 753 | $20.56 | Sell | $15,481.68 | |
| Dec. 3, 2018 | CEO | 3,620 | $20.60 | Sell | $74,572.00 | |
| Nov. 29, 2018 | Major Shareholder | 50,000 | $20.20 | Sell | $1,010,000.00 | |
| Nov. 26, 2018 | Director | 1,904 | $19.98 | Sell | $38,041.92 | |
| Oct. 11, 2018 | Major Shareholder | 143,576 | $16.98 | Sell | $2,437,920.48 | |
| Oct. 9, 2018 | Major Shareholder | 153,858 | $17.28 | Sell | $2,658,666.24 | |
| Oct. 4, 2018 | Major Shareholder | 126,464 | $19.15 | Sell | $2,421,785.60 | |
| Oct. 2, 2018 | Major Shareholder | 32,649 | $18.89 | Sell | $616,739.61 | |
| Sept. 6, 2018 | Major Shareholder | 13,829 | $27.82 | Sell | $384,722.78 | |
| Sept. 4, 2018 | Major Shareholder | 200 | $29.00 | Sell | $5,800.00 | |
| Aug. 28, 2018 | Major Shareholder | 20,256 | $29.41 | Sell | $595,728.96 | |
| Aug. 1, 2018 | Insider | 6,250 | $24.69 | Sell | $154,312.50 | |
| July 25, 2018 | Major Shareholder | 86,551 | $28.61 | Sell | $2,476,224.11 | |
| July 23, 2018 | Major Shareholder | 25,000 | $28.32 | Sell | $708,000.00 | |
| July 20, 2018 | Major Shareholder | 108,740 | $29.09 | Sell | $3,163,246.60 | |
| July 17, 2018 | Major Shareholder | 33,299 | $30.04 | Sell | $1,000,301.96 | |
| July 13, 2018 | Major Shareholder | 100 | $30.00 | Sell | $3,000.00 | |
| July 10, 2018 | Major Shareholder | 200,354 | $30.61 | Sell | $6,132,835.94 | |
| July 5, 2018 | Major Shareholder | 27,093 | $30.10 | Sell | $815,499.30 | |
| July 2, 2018 | Major Shareholder | 35,889 | $30.06 | Sell | $1,078,823.34 | |
| July 2, 2018 | Insider | 5,000 | $29.61 | Sell | $148,050.00 | |
| June 28, 2018 | Insider | 5,859 | $27.84 | Sell | $163,114.56 | |
| June 20, 2018 | Major Shareholder | 58,700 | $30.37 | Sell | $1,782,719.00 | |
| June 18, 2018 | Major Shareholder | 243,414 | $30.77 | Sell | $7,489,848.78 | |
| June 15, 2018 | Major Shareholder | 216,910 | $31.62 | Sell | $6,858,694.20 | |
| June 15, 2018 | Director | 25,000 | $31.42 | Sell | $785,500.00 | |
| June 12, 2018 | Major Shareholder | 167,773 | $31.27 | Sell | $5,246,261.71 |
Insiders are both buying and selling Acorda Therapeutics Inc stock.
The insider traders at Acorda Therapeutics Inc are: Scopia Capital Management Lp, Ron Cohen, Jane Wasman, David Lawrence, Andrew A Hindman, Andrew Blight, Lauren M Sabella, Burkhard Blank, Lorin Randall, Enrique J Carrazana, Steven M Rauscher, Ian F Smith, Lauren M. Sabella, Michael W Rogers, Sandra Phd Panem, John Kelley, Enrique Carrazana, Michael W. Rogers, Richard P Batycky, Ian F. Smith, John P Kelley, Barry E Greene, and Lauren Sabella
The most active insider trader at Acorda Therapeutics Inc is Scopia Capital Management Lp with 40 trades.
Scopia Capital Management Lp has sold the most Acorda Therapeutics Inc stock with a total value of $75,520,737.84.
Scopia Capital Management Lp has bought the most Acorda Therapeutics Inc stock with a total value of $29,468,090.46.
The most recent insider trade for Acorda Therapeutics Inc was on March 16, 2023.
The single biggest insider buy for Acorda Therapeutics Inc was from Scopia Capital Management Lp with a total value of $14,734,045.23 on Aug. 29, 2017.
The single biggest insider sell for Acorda Therapeutics Inc was from Scopia Capital Management Lp with a total value of $7,489,848.78 on June 18, 2018.